Lukas Schulig (L Schulig)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 14

Top Venues

Expert opinion on drug discovery

ChemMedChem

Cancers

Journal of chemical information and modeling

University of Greifswald

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Greifswald Oct 1o 2017

Germany

Doctoral student :: Pharmaceutical and Medicinal Chemistry

Publications

Felix Potlitz, Andreas Link, Lukas Schulig
Advances in the discovery of new chemotypes through ultra-large library docking. Expert opinion on drug discovery 18 (3) (2023)
Felix Potlitz, Andreas Link, Lukas Schulig
Advances in the discovery of new chemotypes through ultra-large library docking. Expert opinion on drug discovery 18 (3) (2023)
Felix Potlitz, Andreas Link, Lukas Schulig
Advances in the discovery of new chemotypes through ultra-large library docking. Expert opinion on drug discovery (2023)
Felix Potlitz, Andreas Link, Lukas Schulig
Advances in the discovery of new chemotypes through ultra-large library docking. Expert opinion on drug discovery 18 (3) (2023)
Felix Potlitz, A Link, Lukas Schulig
Advances in the discovery of new chemotypes through ultra-large library docking. Expert opinion on drug discovery (2023)
Konrad W Wurm, Frieda-Marie Bartz, Lukas Schulig, Anja Bodtke, Patrick J Bednarski, Andreas Link
Modifications of the Triaminoaryl Metabophore of Flupirtine and Retigabine Aimed at Avoiding Quinone Diimine Formation. ACS omega 7 (9) (2022)
Lukas Schulig, Norman Geist, Mihaela Delcea, Andreas Link, Martin Kulke
Fundamental Redesign of the TIGER2hs Kernel to Address Severe Parameter Sensitivity. Journal of chemical information and modeling 62 (17) (2022)
Konrad W Wurm, Frieda-Marie Bartz, Lukas Schulig, Anja Bodtke, Patrick J Bednarski, Andreas Link
Carba Analogues of Flupirtine and Retigabine with Improved Oxidation Resistance and Reduced Risk of Quinoid Metabolite Formation. ChemMedChem 17 (16) (2022)
Tobias Auel, Linus Großmann, Lukas Schulig, Werner Weitschies, Anne Seidlitz
The EyeFlowCell: Development of a 3D-Printed Dissolution Test Setup for Intravitreal Dosage Forms. Pharmaceutics 13 (9) (2021)
Steven Behnisch-Cornwell, Christoph W Grathwol, Lukas Schulig, Anika Voigt, Daniel Baecker, Andreas Link, Patrick J Bednarski
Correlation Analysis of Protein Expression of 10 HDAC/Sirtuin Isoenzymes with Sensitivities of 23 Anticancer Drugs in 17 Cancer Cell Lines and Potentiation of Drug Activity by Co-Treatment with HDAC Inhibitors. Cancers 14 (1) (2021)
Martin Kulke, Felix Nagel, Lukas Schulig, Norman Geist, Marcel Gabor, Julia Mayerle, Markus M Lerch, Andreas Link, Mihaela Delcea
A Hypothesized Mechanism for Chronic Pancreatitis Caused by the N34S Mutation of Serine Protease Inhibitor Kazal-Type 1 Based on Conformational Studies. Journal of inflammation research 14 (2021)
Lukas Schulig, Piotr Grabarczyk, Norman Geist, Martin Delin, Hannes Forkel, Martin Kulke, Mihaela Delcea, Christian A Schmidt, Andreas Link
Unveiling the N-Terminal Homodimerization of BCL11B by Hybrid Solvent Replica-Exchange Simulations. International journal of molecular sciences 22 (7) (2021)
Christoph W Grathwol, Nathalie Wössner, Steven Behnisch-Cornwell, Lukas Schulig, Lin Zhang, Oliver Einsle, Manfred Jung, Andreas Link
Activation of Sirtuin 2 Inhibitors Employing Photoswitchable Geometry and Aqueous Solubility. ChemMedChem 15 (15) (2020)
Robert Klaus Hofstetter, Felix Potlitz, Lukas Schulig, Simon Kim, Mahmoud Hasan, Andreas Link
Subcritical Fluid Chromatography at Sub-Ambient Temperatures for the Chiral Resolution of Ketamine Metabolites with Rapid-Onset Antidepressant Effects. Molecules (Basel, Switzerland) 24 (10) (2019)

Lukas Schulig.css-eqlu8i{font-size:small;padding-left:4px;} (L Schulig)

Publication Activity (10 Years)

Top Topics

Top Venues

Lukas Schulig (L Schulig)